Easy and stereoselective synthesis of cyclopropyl-substituted phosphonates via α-chlorophosphonates

Synthesis

Volumn , Issue 10, 2007, Pages 1485-1490

  Kumara Swamy, K C ^a   Pavan Kumar, K V P ^a   Rama Suresh, R ^a   Satish Kumar, N ^a  

^a UNIVERSITY OF HYDERABAD   (India)

Author keywords

Acrylates; Cyclopropanes; Diastereomers; Michael addition; Phosphonates

Indexed keywords

CYCLOPROPANES; DIASTEREOMERS; MICHAEL ADDITION; PHOSPHONATES;

ADDITION REACTIONS; ESTERS; NEGATIVE IONS; SODIUM COMPOUNDS; STEREOSELECTIVITY; SUBSTITUTION REACTIONS; SYNTHESIS (CHEMICAL);

PHOSPHORUS COMPOUNDS;

2 [BROMO(4 METHOXYPHENYL)METHYL] 5,5 DIMETHYL 1,3,2 DIOXAPHOSPHINANE 2 OXIDE; ACRYLIC ACID DERIVATIVE; ALKYL ACRYLIC ACID; ALPHA CHLOROPHOSPHONIC ACID DERIVATIVE; CHLORIDE ION; CYCLOPROPANE DERIVATIVE; CYCLOPROPANECARBOXYLIC ACID DERIVATIVE; DICARBOXYLIC ACID; DIMETHYL 3 (4 CHLOROPHENYL) 3 (5,5 DIMETHYL 2 OXO 2LAMBDA 5 1,3,2 DIOXAPHOSPHINAN 2 YL)CYCLOPROPANE 1,2 DICARBOXYLIC ACID; DIMETHYL 3 (5,5 DIMETHYL 2 OXO 2LAMBDA 5 1,3,2 DIOXAPHOSPHINAN 2 YL) 3 PHENYLCYCLOPROPANE 1,2 DICARBOXYLIC ACID; DIMETHYL MALEIC ACID; ETHYL 2 (5,5 DIMETHYL 2 OXO 2LAMBDA 5 1,3,2 DIOXAPHOSPHINAN 2 YL) 2 (4 TOLYL)CYCLOPROPANECARBOXYLIC ACID; ETHYL 2 (5,5 DIMETHYL 2 OXO 2LAMBDA 5 1,3,2 DIOXAPHOSPHINAN 2 YL) 2 PHENYLCYCLOPROPANECARBOXYLIC ACID; FUMARIC ACID; MALEIC ACID DERIVATIVE; METHYL 2 (5,5 DIMETHYL 2 OXO 2LAMBDA 5 1,3,2 DIOXAPHOSPHINAN 2 YL) 1 METHYL 2 (P TOLYL)CYCLOPROPANECARBOXYLIC ACID; METHYL 2 (5,5 DIMETHYL 2 OXO 2LAMBDA 5 1,3,2 DIOXAPHOSPHINAN 2 YL) 1 METHYL 2 PHENYLCYCLOPROPANECARBOXYLIC ACID; METHYL 2 (5,5 DIMETHYL 2 OXO 2LAMBDA 5 1,3,2 DIOXAPHOSPHINAN 2 YL) 2 (4 METHOXYPHENYL)CYCLOPROPANECARBOXYLIC ACID; METHYL 2 (5,5 DIMETHYL 2 OXO 2LAMBDA 5 1,3,2 DIOXAPHOSPHINAN 2 YL) 2 (4 TOLYL)CYCLOPROPANECARBOXYLIC ACID; METHYL 2 (5,5 DIMETHYL 2 OXO 2LAMBDA 5 1,3,2 DIOXAPHOSPHINAN 2 YL) 2 PHENYLCYCLOPROPANECARBOXYLIC ACID; PHOSPHONIC ACID DERIVATIVE; UNCLASSIFIED DRUG;

ARTICLE; CHEMICAL STRUCTURE; MICHAEL ADDITION; STEREOCHEMISTRY; SYNTHESIS;

EID: 34249785925     PISSN: 00397881     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-966032     Document Type: Article

References (33)

1. Zwierzak, A. Can. J. Chem. 1967, 45, 2501.
2. (a) Kumaraswamy, S.; Selvi, R. S.; Kumara Swamy, K. C. Synthesis 1997, 207.
3. (b) Kumaraswamy, S.; Kumara Swamy, K. C. Tetrahedron Lett. 1997, 38, 2183.
4. (c) Praveen Kumar, K.; Muthiah, C.; Kumaraswamy, S.; Kumara Swamy, K. C. Tetrahedron Lett. 2001, 42, 3219.
5. (d) Muthiah, C.; Senthil Kumar, K.; Vittal, J. J.; Kumara Swamy, K. C. Synlett 2002, 1787.
6. (e) Chakravarty, M.; Srinivas, B.; Muthiah, C.; Kumara Swamy, K. C. Synthesis 2003, 2368.
7. (f) Kumara Swamy, K. C.; Kumaraswamy, S.; Senthil Kumar, K.; Muthiah, C. Tetrahedron Lett. 2005, 46, 3347.
8. (a) Muthiah, C.; Praveen Kumar, K.; Kumaraswamy, S.; Kumara Swamy, K. C. Tetrahedron 1998, 54, 14315.
9. (b) Muthiah, C.; Praveen Kumar, K.; Aruna Mani, C.; Kumara Swamy, K. C. J. Org. Chem. 2000, 65, 3733.
10. (c) Senthil Kumar, K.; Kumara Swamy, K. C. J. Organomet. Chem. 2001, 637-639, 616.
11. (d) Chakravarty, M.; Kumara Swamy, K. C. J. Org. Chem. 2006, 71, 9128.
12. (e) Kumara Swamy, K. C.; Balaraman, E.; Kumar, N. S. Tetrahedron 2006, 62, 10152.
13. Hanessian, S.; Cantin, L.-D.; Roy, S.; Andreotti, D.; Gomtsyan, A. Tetrahedron Lett. 1997, 38, 1103.
14. Yuan, C.; Li, C.; Ding, Y. Synthesis 1991, 854.
15. (a) Sitachitta, N.; Gerwick, W. H. J. Nat. Prod. 1998, 61, 681.
16. (b) Cao, B.; Xiao, D.; Joullie, M. M. Org. Lett. 1999, 1, 1799.
17. (c) Esposito, A.; Piras, P. P.; Ramazzotti, D.; Taddei, M. Org. Lett. 2001, 3, 3273.
18. (d) Ono, S.; Ogawa, K.; Yamashita, K.; Yamamoto, T.; Kazuta, Y.; Matsuda, A.; Shuto, S. Chem. Pharm. Bull. 2002, 50, 966.
19. (e) Kazuta, Y.; Matsuda, A.; Shuto, S. J. Org. Chem. 2002, 67, 1669.
20. (f) Frydman, B.; Blokhin, A. V.; Brummel, S.; Wilding, G.; Maxuitenko, Y.; Sarkar, A.; Bhattacharya, S.; Church, D.; Reddy, V. K.; Kink, J. A.; Marton, L. J.; Valasinas, A.; Basu, H. S. J. Med. Chem. 2003, 46, 4586.
21. (g) Janjic, J. M.; Mu, Y.; Kendall, C.; Stephenson, C. R. J.; Balachandran, R.; Raccor, B. S.; Lu, Y.; Zhu, G.; Xie, W.; Wipf, P.; Day, B. W. Bioorg. Med. Chem. 2005, 13, 157.
22. (h) Reichelt, A.; Martin, S. F. Acc Chem. Res. 2006, 39, 433.
23. (a) Yamaguchi, M.; Tsukamoto, Y.; Hayashi, A.; Minami, T. Tetrahedron Lett. 1990, 31, 2423.
24. (b) Haynes, R. K.; Stokes, J. P.; Hambley, T. W. J. Chem. Soc., Chem. Commun. 1991, 58.
25. (c) Haynea, R. K.; Vonwiller, S. C.; Hambley, T. W. J. Org. Chem. 1989, 54, 5162.
26. (d) Hanessian, S.; Gomtsyan, A.; Payne, A.; Herve, Y.; Beaudoin, S. J. Org. Chem. 1993, 58, 5032.
27. 2a Note that 2-(1-hydroxy-3-phenyl-prop-2-enyl)-5,5- dimethyl-1,3,2-dioxaphosphinane 1-oxide affords two types of cinnamyl-substituted bromophosphonates 2-(1-bromo-3-phenylprop-2-enyl)-5,5- dimethyl-1,3,2-dioxaphosphinane 1-oxide and 2-(3-bromo-3-phenyl-prop-1-enyl)-5, 5-dimethyl-1,3,2-dioxaphosphinane 1-oxide, while the using 2-[hydroxy(2-furyl) methyl]-5,5-dimethyl-1,3,2-dioxaphosphinane 1-oxide affords 2-(5-bromo-2-furyl)- 5,5-dimethyl-1,3,2-dioxaphosphinane 1-oxide. More details are available from the authors or in ref. 9.
28. Pavan Kumar, K. V. P. PhD Thesis; University of Hyderabad: India, 2006.
29. All data has been deposited at the Cambridge database. We believe that such information will be useful, in case these compounds are pharmacologically active.
30. Perrin, D. D.; Armarego, W. L. F.; Perrin, D. R. Purification of Laboratory Chemicals; Pergamon: Oxford, 1986.
31. (a) Sheldrick G. M., SHELX-97, University of Göttingen, Germany, 1997.
32. (b) Sheldrick G. M., SADABS, Siemens Area Detector Absorption Correction, University of Göttingen, Germany, 1996.
33. (c) Sheldrick G. M., SHELXTL NT, version 5.10; Bruker AXS, Analytical X-ray System, WI, 1999.